Joe Lonsdale on AI regulation: National review should be as limited and targeted as possible

Summary

Joe Lonsdale discusses AI regulation, arguing against heavy-handed oversight and warning of big tech capture. He also addresses defense spending inefficiencies and claims China is funding AI doomism to slow US progress.

• Lonsdale criticizes the FDA model as a cautionary tale for AI regulation, calling for limited and targeted rules.
• He asserts that big tech companies want regulation to entrench their market power and slow innovation.
• He highlights defense tech startups building cheaper solutions, such as $5,000 drone interceptors vs. million-dollar missiles.
• Lonsdale claims China is funding NGOs and activists to spread AI doomism and oppose data center construction.
• He emphasizes that the US is currently leading in AI and must continue building confidently.
• He warns against government-corporate collusion in regulation, drawing parallels to healthcare and pharma.